Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LY4050784 |
Trade Name | |
Synonyms | LY 4050784|LY-4050784|FHD-909|FHD 909|FHD909 |
Drug Descriptions |
LY4050784 inhibits SMARCA2 (BRM) and SMARCA4 (BRG1), potentially leading to decreased tumor growth (Mol Cancer Ther (2024) 23 (6_Supplement): PR015). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LY4050784 | LY4050784 | 0 | 1 |